Share This Page
Suppliers and packagers for spironolactone
✉ Email this page to a colleague
spironolactone
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Amneal | SPIRONOLACTONE | spironolactone | SUSPENSION;ORAL | 215572 | ANDA | ATLANTIC BIOLOGICALS CORP. | 17856-2028-3 | 60 SYRINGE in 1 PACKAGE (17856-2028-3) / 10 SYRINGE in 1 SYRINGE (17856-2028-2) / 2.5 mL in 1 SYRINGE (17856-2028-1) | 2023-09-08 |
| Amneal | SPIRONOLACTONE | spironolactone | SUSPENSION;ORAL | 215572 | ANDA | Amneal Pharmaceuticals NY LLC | 69238-2027-2 | 473 mL in 1 BOTTLE (69238-2027-2) | 2023-09-08 |
| Amneal | SPIRONOLACTONE | spironolactone | SUSPENSION;ORAL | 215572 | ANDA | Amneal Pharmaceuticals NY LLC | 69238-2027-8 | 118 mL in 1 BOTTLE (69238-2027-8) | 2023-09-08 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Spironolactone
Introduction
Spironolactone is a well-established pharmaceutical used primarily as a diuretic and in the treatment of conditions such as hypertension, heart failure, edema, and hormone-related disorders like hyperaldosteronism and certain dermatological conditions. As a synthetic steroidal compound, spironolactone’s manufacturing process requires high quality control, making the supplier network a vital aspect of its global availability. The industry landscape is characterized by a diverse group of manufacturers ranging from branded pharmaceutical companies to generic drug producers, spanning multinational corporations to regional and emerging-market players.
This comprehensive review offers insight into the key suppliers of spironolactone, analyzing their market share, manufacturing footprints, quality standards, and strategic positioning within the pharmaceutical supply chain. Understanding these suppliers is essential for stakeholders assessing supply security, regulatory compliance, cost implications, and potential collaborations.
Major Global Suppliers of Spironolactone
1. Mylan (Viatris Inc.)
Mylan, now part of Viatris Inc., stands as one of the world’s leading producers of generic pharmaceuticals, including spironolactone. With a broad manufacturing network across North America, Europe, and Asia, Viatris leverages robust production capabilities to meet global demand. Their facilities adhere to Good Manufacturing Practice (GMP) standards recognized by multiple regulatory authorities, such as the U.S. FDA, EMA, and WHO. Viatris supplies spironolactone in various strengths and formulations, serving both branded and generic markets.
2. Pfizer Inc.
Pfizer remains a significant supplier, especially in patent-heavy markets, though much of its production shifted to generics following patent expirations. Pfizer's manufacturing sites in Europe and North America comply with stringent regulatory standards, allowing reliable supply chains for spironolactone worldwide. Pfizer’s longstanding presence and extensive distribution network support its role as a key supplier in developed markets.
3. Teva Pharmaceutical Industries Ltd.
Teva is a dominant player in the generic drug sector, providing spironolactone across various markets. With manufacturing facilities in Israel, Europe, and the United States, Teva ensures high-quality standards. The company's substantial market share derives from cost-effective production and a wide distribution network, which reinforce its position in the global generic spironolactone market.
4. Sandoz (Novartis AG)
Sandoz specializes in generic and biosimilar medicines, including spironolactone. Its manufacturing facilities in Europe and the Americas attain high GMP compliance, ensuring product quality. Sandoz’s strategic focus on affordability and access grants it a significant role in emerging markets and low-to-middle-income countries.
5. Sun Pharmaceutical Industries Ltd.
As one of India’s largest pharmaceutical companies, Sun Pharma produces spironolactone both for domestic consumption and export. The company’s manufacturing plants in India are WHO GMP-certified, and Sun Pharma has been expanding its presence into international markets, especially Africa and Southeast Asia. Its competitive pricing and compliance with international standards position it as an essential supplier for cost-sensitive markets.
6. pharmaceutical companies in China and India
The burgeoning pharmaceutical sectors in China and India contribute substantially to spironolactone supply. Companies such as China’s CSPC Pharmaceutical Group and India’s Aurobindo Pharma manufacture cost-effective versions of spironolactone that serve both domestic markets and exports. These producers benefit from local regulatory approvals, GRAS (Generally Recognized as Safe) standards, and partnerships with global entities seeking affordable sourcing options.
Specialized and Emerging Suppliers
Beyond the established giants, several regional and emerging-market firms are increasing their presence through investments in API (Active Pharmaceutical Ingredient) synthesis and formulation development. Notable among these are:
- Hovid Berhad (Malaysia): Known for producing generic APIs, including spironolactone, mainly catering to Southeast Asian markets.
- Glenmark Pharmaceuticals (India): Focused on both API manufacturing and finished formulations, expanding into global markets with cost-effective options.
- Aurobindo Pharma (India): Noteworthy for its vertically integrated API and formulation production, ensuring supply chain control and competitive pricing.
Supply Chain Dynamics and Regulatory Considerations
The supply chain for spironolactone hinges on the procurement of high-purity APIs, which requires access to reliable manufacturing, robust quality assurance, and compliance with international standards [1]. Regulatory agencies such as the FDA, EMA, and WHO conduct rigorous inspections of manufacturing plants. Suppliers with multiple certifications and proven track records generally possess competitive advantages, including expanded market access and minimized risks of production delays.
Additionally, geopolitical factors and regional trade policies influence supplier viability. The COVID-19 pandemic underscored vulnerabilities in supply chains, pushing stakeholders to diversify suppliers and invest in local or regional manufacturing capabilities to enhance resilience [2].
Market Trends and Future Outlook
- Consolidation: The industry has seen increased mergers, acquisitions, and partnerships aimed at streamlining supply and expanding portfolio offerings.
- API Manufacturing Expansion: Companies are investing in API synthesis capacity in mapping to regional demand, especially in Asia.
- Regulatory Harmonization: Efforts to align standards across jurisdictions enhance supplier credibility and facilitate market access.
- Sustainability and Green Chemistry: Suppliers increasingly adopt environmentally sustainable methods to meet regulatory and societal expectations.
Key Challenges
- Quality Assurance: Maintaining high API purity and consistency remains paramount amidst global supply demands.
- Intellectual Property: Although spironolactone patents have expired, ongoing patent challenges in some jurisdictions may influence supplier strategies.
- Supply Security: Dependency on specific regions or manufacturers risks disruptions, incentivizing diversification.
Key Takeaways
- The global spironolactone supply chain is primarily led by generic pharmaceutical giants such as Viatris, Teva, Sandoz, and Sun Pharma.
- Asian manufacturers, notably those in India and China, play an increasingly vital role in providing affordable spironolactone APIs, especially for emerging markets.
- Regulatory compliance, quality assurance, and diversified sourcing are critical to mitigate risks associated with supply chain disruptions.
- Strategic partnerships and capacity investments are shaping the evolution of supplier networks to meet growing global demands.
- Stakeholders should prioritize suppliers with proven GMP compliance, certification credentials, and reliable delivery histories for sourcing spironolactone.
FAQs
1. Who are the leading suppliers of spironolactone globally?
Major global suppliers include Viatris (Mylan), Pfizer, Teva, Sandoz (Novartis), and Sun Pharma. These companies have extensive manufacturing capabilities and regulatory approvals, making them key players in the supply of spironolactone worldwide.
2. Are Chinese and Indian pharmaceutical companies reliable suppliers for spironolactone?
Yes. Several Indian and Chinese manufacturers operate GMP-certified factories that meet international standards. They provide cost-effective APIs and formulations, particularly for emerging markets. However, buyers should rigorously evaluate regulatory compliance and quality systems.
3. How has recent industry consolidation affected spironolactone supply?
Industry consolidation through mergers and alliances has enhanced manufacturing efficiencies, supply reliability, and market reach. It allows companies to optimize API sourcing, reduce costs, and better meet demand fluctuations.
4. What regulatory considerations impact suppliers of spironolactone?
Suppliers must adhere to GMP standards verified by agencies such as the FDA, EMA, and WHO. Non-compliance can lead to market restrictions, recall issues, and supply disruptions. Certifications and inspection histories are crucial assessment factors.
5. Is there a trend toward alternative or biosimilar sources for spironolactone?
While spironolactone is a small molecule and not typically biosimilar, there is a trend toward developing generic formulations and novel delivery mechanisms, including sustained-release versions, which may involve alternative API sources.
References
[1] U.S. Food & Drug Administration. (2021). Guidance for Industry: Quality Considerations for API Manufacturing.
[2] World Health Organization. (2021). Pandemic Impact on Pharmaceutical Supply Chains: A Global Perspective.
More… ↓
